Effect of intravenous iron therapy in improving hemoglobin among women after delivery of baby
Phase 4
- Conditions
- Health Condition 1: null- Post partum women with moderate to severe anemia
- Registration Number
- CTRI/2018/06/014432
- Lead Sponsor
- Centre for Community Medicine AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a.Post-partum women with hemoglobin levels 5.0 g/dl to 9.9 g/dl
b.Those who give written consent and agree to cooperate for all measurements at different time points
Exclusion Criteria
a)Women with renal or hepatic impairment.
b)Women having hemoglobin <5gm%.
c)Women with history of parenteral iron administration during current pregnancy.
d)Allergy to iron preparations.
e)Known case of thalassemia, sickle cell anaemia or haemolytic anaemia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the change in mean haemoglobin level six weeks after intravenous administration of Ferric Carboxy Maltose (FCM) amongst postpartum women with moderate or severe anaemia who delivered at a Sub District HospitalTimepoint: six weeks
- Secondary Outcome Measures
Name Time Method To document any adverse events following administration of FCMTimepoint: From the time of FCM administration to six weeks after intervention